endocarditis, natieve klep - HACEK
Advices
Priority | Medication | Remarks |
---|---|---|
Medication: ceftriaxon iv 2000mg 2dd 1 days followed by
ceftriaxon iv 2000mg 1dd 4 weeks |
Remarks:
Empirisch |
|
Medication: amoxicilline iv loading dose 2g, 12g continuous per 24 hours 4 weeks |
Remarks:
Indien verwekker beta-lactamase negatief |
|
Medication: ciprofloxacine iv 400mg 2dd 4 weeks or
ciprofloxacine po 500mg 2dd 4 weeks |
Remarks:
Bij beta-lactam allergie |
Sources
- SWAB Richtlijn Infectieuze Endocarditis
- Endocarditis protocol UMCG
- European Society of Cardiology (ESC): Infective Endocarditis (Guidelines on Prevention, Diagnosis and Treatment of)
-
Pubmed.gov publication # 26373316
Circulation. 2015 Oct 13;132(15):1435-86.
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association.
-
Pubmed.gov publication # 19713420
Eur Heart J. 2009 Oct;30(19):2369-413.
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.
-
Pubmed.gov publication # 22086858
J Antimicrob Chemother. 2012 Feb;67(2):269-89.
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-211184.9
Updated: 11/30/2022 - 12:32
Status: Published
General comments
Overleg met endocarditis-team (internist-infectioloog of arts-microbioloog)
Advies ongewijzigd gepubliceerd na beoordeling in kader van revisie SWABID UMCG in opdracht van CAM 1-8-2022